NR1D1 and myopia: Our study shows that NR1D1, PPP1R18, PGBD2, and PPP1R3D are effective as biomarkers in the diagnosis of myopia and that NR1D1, PPP1R18, PGBD2, and PPP1R3D may be potential therapeutic targets.